Open Journal Systems

Cover Image

An outlook on the havoc post-COVID-19 outbreak: A current status and consequences

Tushar Dubey, Apurv Soni, Shyamalendu Laskar, Pritam Pohankar

Abstract


Background: The only thing that world is most vigilant about, now, is COVID-19. An outbreak of a disease of a type of pneumonia, caused by group of coronavirus, has created havoc in around more than 180 countries and regions worldwide and has claimed numbers of lives around the globe. The virus was named SARS-COV-2 belongs to the family of coronaviruses, which is believed to have originated from bats. It was declared pandemic by the World Health Organization on March 11, 2020. It is seen that virus spreads by human-to-human transmission. Aim: To combat this virus, numerous measures are being taken. Effective vaccine has not been available thus far. However, it is been noted that the disease subsides by the administration of antiviral drugs and this mode of treatment has high success rate. Importance of social responsibility and refraining from spreading medically and scientifically invalidated information needs to be emphasized. Conclusion: The novel coronavirus spread so rapidly that it has change the rhythm of the globe, its current and future consequences on socioeconomic status and health-care facilities going to be a challenge for the country. However, every country is facing the crisis based on their own possibilities, expertise, and hypotheses. Thus, there are different criteria for testing, estimation, and hospitalization of cases making it difficult to calculate the number of people affected by pandemic. This review article summarizes the information about the virus, epidemiology, prevalence, current status in India, and the future impact of it on various strata. Clinical Significance: The clinical symptoms of COVID-19 may vary from symptomatic to asymptomatic forms which is characterized by severe respiratory failure, cough, myalgia, and fever. It is difficult to differentiate COVID-19 from other viral infections, symptoms are changing day by day. The incubation period can last longer than 2 weeks and it is possible that a very long incubation period could reflect double exposure. Suspected and confirmed cases should be treated in designated hospitals with effective isolation and protective conditions in a single room. Moreover, critical cases need to be admitted to the intensive care unit as soon as possible.

Keywords


COVID-19; disease outbreak; pandemic

Full Text:

Abstract PDF

References


Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.

Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71-6.

Sanjuán R, Domingo-Calap P. Mechanisms of viral mutation. Cell Mol Life Sci 2016;73:4433-48.

Khanna RC, Cicinelli MV, Gilbert SS, Honavar SG, Murthy GS. COVID-19 pandemic: Lessons learned and future directions. Indian J Ophthalmol 2020;68:703-10.

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020;395:514-23.

Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agents 2020;55:105951.

World Health Organization. Coronavirus Disease 2019: Situation Report, 73. Geneva: World Health Organization; 2020.

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. Int J Environ Res Public Health 2020;17:2690.

World Health Organization. India Situation Report. Coronavirus Disease 2019: Situation Report, 17. Geneva: World Health Organization; 2020.

Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020;5:562-9.

Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res 2018;149:58-74.

Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3.

Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, et al. Middle east respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res 2014;194:200-10.

Villar J, Zhang H, Slutsky AS. Lung repair and regeneration in ARDS: Role of PECAM1 and Wnt signaling. Chest 2019;155:587- 94.

Channappanavar R, Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39.

Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008;26:711-5.

Pyle CJ, Uwadiae FI, Swieboda DP, Harker JA. Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology. PLoS Pathog 2017;13:e1006640.

Chen C, Zhang XR, Ju ZY, He WF. Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019. Zhonghua Shao Shang Za Zhi 2020;36:471-5.

Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncol 2020;106:104659.

Raj K, Bhatia R, Ghosh A, Singh S. Coronavirus as silent killer: Recent advancement to pathogenesis, therapeutic strategy and future perspectives. Virus disease 2020;31:1-9.

Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020;11:827.

Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist 2020;21:22-7.

World Health Organization. Coronavirus Disease 2019: Situation Report, 71. Geneva: World Health Organization; 2020.

Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and CoVID-19: The most important research questions. Cell Biosci 2020;10:1-5.

Wang H, Wang S, Yu K. COVID-19 infection epidemic: The medical management strategies in Heilongjiang Province, China. Crit Care 2020;24:107.

Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother 2020;64:e00399-20.

Boldog P, Tekeli T, Vizi Z, Dénes A, Bartha FA, Röst G. Risk assessment of novel coronavirus COVID-19 outbreaks outside China. J Clin Med 2020;9:571.

World Health Organization. India Situation Report. Coronavirus Disease 2019: Situation Report, 16. Geneva: World Health Organization; 2020.


Refbacks

  • There are currently no refbacks.
x
Message